
Rezurock is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
from FDA,2024.04
What is the mechanism of action of belumosudil?Belumosudil is a prescription medicine specifically indicated for the treatment of chronic graft-versus-host disease (cGVHD) in adult···【more】
Article source:Lucius LaosRelease date:2026-04-07Recommended:36
Unique Immune Modulating Mechanism of BelumosudilChronic GVHD is characterized by severe immune system imbalance. Following hematopoietic stem cell transplantation, donor immune ce···【more】
Article source:Lucius LaosRelease date:2026-04-02Recommended:54
iIndicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease .【more】
Article source:Lucius LaosRelease date:2026-01-05Recommended:30

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: